Wegovy - European Public Assessment Report
For GLP-1 reconstitution in Bacteriostatic Water, the DPP-IV inhibitor requirement for biological matrix applications applies regardless of reconstitution vehicle , Bacteriostatic Water itself does not contain DPP-IV activity, but any subsequent addition to biological matrices requires DPP-IV inhibitor supplementation
There is no robust body of randomized controlled trial data demonstrating that lipotropic injections cause clinically significant fat loss beyond what the accompanying calorie restriction, activity changes, and clinical monitoring would have produced anyway
Its available in various forms, including creams, gels, and oral supplements
the needles are on the larger size though Great product for weight loss, energy, and maintaining good health
Most gastrointestinal side effects diminish within 4-8 weeks as tolerance develops during dose titration